Alexandria Capital’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $8.65M | Buy |
960,470
+4,943
| +0.5% | +$44.5K | 0.8% | 39 |
|
|
2021
Q2 | $11.4M | Sell |
955,527
-12,978
| -1% | -$155K | 1.06% | 21 |
|
|
2021
Q1 | $12.1M | Sell |
968,505
-35,220
| -4% | -$441K | 1.23% | 14 |
|
|
2020
Q4 | $15.7M | Sell |
1,003,725
-13,105
| -1% | -$205K | 1.66% | 8 |
|
|
2020
Q3 | $9.69M | Buy |
1,016,830
+4,775
| +0.5% | +$45.5K | 1.16% | 17 |
|
|
2020
Q2 | $9.07M | Buy |
1,012,055
+6,936
| +0.7% | +$62.1K | 1.18% | 16 |
|
|
2020
Q1 | $6.4M | Buy |
1,005,119
+48,235
| +5% | +$307K | 1.05% | 29 |
|
|
2019
Q4 | $8.01M | Buy |
956,884
+53,350
| +6% | +$447K | 1.07% | 26 |
|
|
2019
Q3 | $8.18M | Sell |
903,534
-9,469
| -1% | -$85.7K | 1.21% | 22 |
|
|
2019
Q2 | $9.83M | Sell |
913,003
-3,150
| -0.3% | -$33.9K | 1.4% | 16 |
|
|
2019
Q1 | $8.74M | Buy |
916,153
+22,350
| +3% | +$213K | 1.27% | 20 |
|
|
2018
Q4 | $10.3M | Sell |
893,803
-1,626
| -0.2% | -$18.7K | 1.67% | 8 |
|
|
2018
Q3 | $15.2M | Sell |
895,429
-1,753
| -0.2% | -$29.7K | 2.23% | 4 |
|
|
2018
Q2 | $12.7M | Buy |
897,182
+15,649
| +2% | +$222K | 1.91% | 8 |
|
|
2018
Q1 | $16.7M | Sell |
881,533
-43,994
| -5% | -$836K | 2.49% | 4 |
|
|
2017
Q4 | $15.2M | Buy |
+925,527
| New | +$15.2M | 2.21% | 6 |
|